Barclays’s Quipt Home Medical QIPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,166
Closed -$103K 5356
2025
Q4
$103K Hold
29,166
﹤0.01% 4571
2025
Q3
$76.1K Sell
29,166
-3,002
-9% -$6.93K ﹤0.01% 4680
2025
Q2
$57.6K Sell
32,168
-37,761
-54% -$74.5K ﹤0.01% 4687
2025
Q1
$163K Sell
69,929
-25,987
-27% -$71.2K ﹤0.01% 4157
2024
Q4
$293K Buy
95,916
+8,491
+10% +$22.9K ﹤0.01% 4130
2024
Q3
$255K Buy
87,425
+38,635
+79% +$119K ﹤0.01% 4173
2024
Q2
$157K Sell
48,790
-9,674
-17% -$34.7K ﹤0.01% 3698
2024
Q1
$255K Sell
58,464
-27,168
-32% -$123K ﹤0.01% 3982
2023
Q4
$436K Buy
85,632
+55,967
+189% +$268K ﹤0.01% 3968
2023
Q3
$151K Buy
29,665
+15,728
+113% +$84.3K ﹤0.01% 3418
2023
Q2
$74.4K Buy
13,937
+1,609
+13% +$9.5K ﹤0.01% 3678
2023
Q1
$86.4K Buy
+12,328
New +$75.9K ﹤0.01% 4257

Barclays's QIPT Position: Q1 2026 in Review

Barclays sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 29,166 shares — an estimated $103K sold.

Barclays first reported a position in QIPT in Q1 2023 and held it in 12 quarters. The position peaked at $436K in Q4 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.

  • Barclays reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 29,166 Quipt Home Medical shares in Q1 2026, an estimated $103K.
  • Barclays first reported a position in Quipt Home Medical in Q1 2023 and held it in 12 quarters.
  • Barclays's Quipt Home Medical position peaked at $436K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.